Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone's muscle-building effects do not require its conversion to DHT.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Higher free testosterone levels can increase bone density and decrease body fat but may raise the risk of prostate cancer, hair loss, and benign prostate enlargement.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Sex hormones affect liver fat and metabolic health differently in men and women.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Ark-e-Kasni improves PCOS symptoms and may be a potential treatment.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Metformin is less effective in men with early-onset hair loss.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Good preoperative assessment is crucial for safe and effective eyelid and brow cosmetic surgery.

Women with PCOS have higher body fat and worse insulin resistance and lipid profiles.

A low insulinemic diet improves weight, hormone levels, and well-being in women with PCOS.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

Blocking androgen activity in newborn rats affects body weight and appetite-related hormones differently in males and females.